Liposomal anticancer therapy: pharmacokinetic and clinical aspects.
about
Polyplex Nanogel formulations for drug delivery of cytotoxic nucleoside analogs.Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancerDoxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking.In vitro and in vivo reversal of resistance to 5-fluorouracil in colorectal cancer cells with a novel stealth double-liposomal formulation.Nanotechnology for breast cancer therapy.In vitro and in vivo evaluation of lipofufol, a new triple stealth liposomal formulation of modulated 5-fu: impact on efficacy and toxicity.9-Deazaguanine derivatives connected by a linker to difluoromethylene phosphonic acid are slow-binding picomolar inhibitors of trimeric purine nucleoside phosphorylase.Antiproliferative activity of purine nucleoside phosphorylase multisubstrate analogue inhibitors containing difluoromethylene phosphonic acid against leukaemia and lymphoma cells.Advances in nano-delivery systems for doxorubicin: an updated insight.Rapid synthesis of lipid nanoparticles containing hydrophobic inorganic nanoparticles.
P2860
Q24540353-4DDFECBC-1AB0-4DF5-9B9C-DA99DDF10054Q24657308-A5654794-F6A7-4C0C-A870-49EC3692B2EEQ30472420-58399760-A1C3-4B43-B6E9-A64BEADE3604Q36611284-3A8D8E04-3B90-4810-88EA-899D5562F17DQ37229262-AAE1BE7D-A7FF-4D2B-81D5-D69BE1F610D4Q39198848-F0720F52-AF1E-4423-9654-256699FC4606Q39733788-614046D9-4D3D-4623-8B77-276190E795FDQ39747769-56856337-0AD7-4AE5-B744-3F5585282B25Q50106753-BA53E861-427D-4B6F-AFA5-9812C0030A15Q50216735-15155B02-0269-4E13-B137-7EDDD43917B6
P2860
Liposomal anticancer therapy: pharmacokinetic and clinical aspects.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Liposomal anticancer therapy: pharmacokinetic and clinical aspects.
@ast
Liposomal anticancer therapy: pharmacokinetic and clinical aspects.
@en
type
label
Liposomal anticancer therapy: pharmacokinetic and clinical aspects.
@ast
Liposomal anticancer therapy: pharmacokinetic and clinical aspects.
@en
prefLabel
Liposomal anticancer therapy: pharmacokinetic and clinical aspects.
@ast
Liposomal anticancer therapy: pharmacokinetic and clinical aspects.
@en
P2860
P1476
Liposomal anticancer therapy: pharmacokinetic and clinical aspects.
@en
P2093
Di Paolo A
P2860
P356
10.1179/JOC.2004.16.SUPPLEMENT-1.90
P478
16 Suppl 4
P577
2004-11-01T00:00:00Z